Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Mertz

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
RMD Open|September 19, 2022
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosusPhilippe Mertz, Matteo Piga, Elisabetta Chessa, et al.
EMBO Molecular Medicine|August 13, 2025
Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function miceDamien Freytag, Stéphane Giorgiutti, Grégoire Hopsomer, et al.
Autoimmunity Reviews|April 3, 2020
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014Marc Scherlinger, Philippe Mertz, Flora Sagez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 12, 2024
Performance of serum IL-18 levels for the follow-up of patients with familial Mediterranean feverInès Elhani, Laure Calas, Farah Bejar, et al.
Orphanet Journal of Rare Diseases|March 11, 2026
Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrumentPhilippe Mertz, Oliver Sander, Raquel Faria, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 16, 2023
Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification CriteriaLéa Debrut, Margherita Giannini, Delphine Klein, et al.
Autoimmunity Reviews|August 18, 2020
Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective studyPhilippe Mertz, Jean-François Kleinmann, Marc Lambert, et al.
Orphanet Journal of Rare Diseases|May 15, 2025
European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT)Laurent Arnaud, Oliver Sander, Simona Rednic, et al.
Joint Bone Spine|November 19, 2018
The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritisPhilippe Mertz, Alexandre Belot, Ricard Cervera, et al.
Haematologica|May 30, 2020
Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 casesPhilippe Mertz, Emilie Chalayer, Zahir Amoura, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
RMD Open|September 19, 2022
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosusPhilippe Mertz, Matteo Piga, Elisabetta Chessa, et al.
EMBO Molecular Medicine|August 13, 2025
Lymphopenia drives T cell exhaustion in immunodeficient STING gain-of-function miceDamien Freytag, Stéphane Giorgiutti, Grégoire Hopsomer, et al.
Autoimmunity Reviews|April 3, 2020
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014Marc Scherlinger, Philippe Mertz, Flora Sagez, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 12, 2024
Performance of serum IL-18 levels for the follow-up of patients with familial Mediterranean feverInès Elhani, Laure Calas, Farah Bejar, et al.
Orphanet Journal of Rare Diseases|March 11, 2026
Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrumentPhilippe Mertz, Oliver Sander, Raquel Faria, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 16, 2023
Refining Incidence and Characteristics of Inflammatory Myopathies: A Quadruple-Source Capture-Recapture Survey Using the 2017 European League Against Rheumatism/American College of Rheumatology Classification CriteriaLéa Debrut, Margherita Giannini, Delphine Klein, et al.
Autoimmunity Reviews|August 18, 2020
Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: Results of a multicenter open-label prospective studyPhilippe Mertz, Jean-François Kleinmann, Marc Lambert, et al.
Orphanet Journal of Rare Diseases|May 15, 2025
European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT)Laurent Arnaud, Oliver Sander, Simona Rednic, et al.
Joint Bone Spine|November 19, 2018
The relapsing polychondritis damage index (RPDAM): Development of a disease-specific damage score for relapsing polychondritisPhilippe Mertz, Alexandre Belot, Ricard Cervera, et al.
Haematologica|May 30, 2020
Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 casesPhilippe Mertz, Emilie Chalayer, Zahir Amoura, et al.
Pageof 5